BioSpace News Archive

Policy

ASLAN Pharmaceuticals Announces Shortened Timeline to Commercialisation for Varlitinib in China

The commercialisation of varlitinib in China is expected to begin approximately one year earlier than previously anticipated following recent discussions with the CFDA regarding its planned clinical development strategy for varlitinib in biliary tract cancer.

January 8, 2018
·
5 min read
Biotech Beach

Illumina Launches iSeq 100 Sequencing System

The new, next-generation sequencing (NGS) system delivers exceptional data accuracy, at a low capital cost, making Illumina technology available to virtually any lab.

January 8, 2018
·
4 min read
Pharm Country

Helius Medical Technologies and HealthTech Connex Announce EEG Study Showing Stimulation by the Investigational PoNS Device Impacts Brain Activity

Brain waves were recorded from each participant for 20 minutes before using the PoNS.

January 8, 2018
·
7 min read
Business

TG Therapeutics and Jiangsu Hengrui Medicine Announce Global License Agreement for Development and Commercialization of Novel BTK Inhibitor Program for the Treatment of Hematologic Malignancies

In addition to TG-1701, the global license agreement covers TG-1702 (SHR-1266), another BTK inhibitor in pre-clinical development.

January 8, 2018
·
7 min read
Drug Development

NewLink Genetics Outlines 2018 Business Priorities to Support Phase III Pivotal Trial of Indoximod Plus PD-1 Inhibitors

In addition, the company updated clinical and financial guidance and provided preliminary unaudited financial information for year-end 2017.

January 8, 2018
·
5 min read
Genetown

Mersana Therapeutics Outlines 2017 Milestones and 2018 Goals

The Company will provide further details during its presentation at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 10, 2018 at 4:00 pm PT.

January 8, 2018
·
6 min read
Business

OCuSOFT Partners With I-MED Pharma to Bring the I-PEN Osmolarity System to the U.S.

This distribution partnership will officially commence upon final FDA approval of the 510k, which is anticipated in the first quarter of 2018.

January 8, 2018
·
4 min read
Neurotech Release: Data Collection at U.S. Clinical Trial Completed, Analysis Underway

Neurotech is pleased to announce that the US Clinical Trial for its Mente Autism device has been completed and analysis is underway.

January 8, 2018
·
2 min read
Silence Therapeutics: Post Year End Business Update

Silence Therapeutics announces a post year end update.

January 8, 2018
·
5 min read
Business

UroGen Pharma Appoints Former Kite Pharma Executive Christine Cassiano as Corporate Affairs Officer

Ms. Cassiano is a communications executive with wide experience in investor relations, corporate communications, media relations, brand strategy and public affairs.

January 8, 2018
·
5 min read